MA32316B1 - Derives spiro-indoles pour le traitement de maladies parasitaires - Google Patents

Derives spiro-indoles pour le traitement de maladies parasitaires

Info

Publication number
MA32316B1
MA32316B1 MA33365A MA33365A MA32316B1 MA 32316 B1 MA32316 B1 MA 32316B1 MA 33365 A MA33365 A MA 33365A MA 33365 A MA33365 A MA 33365A MA 32316 B1 MA32316 B1 MA 32316B1
Authority
MA
Morocco
Prior art keywords
treatment
spiro
plasmodium
indole derivatives
parasitic diseases
Prior art date
Application number
MA33365A
Other languages
Arabic (ar)
English (en)
Inventor
Shi Hua Ang
Philipp Krastel
Seh Yong Leong
Liying Jocelyn Tan
Wei Lin Josephine Wong
Bryan Ks Yeung
Bin Zou
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40613087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32316(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA32316B1 publication Critical patent/MA32316B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

L'invention concerne des composés organiques qui présentent des propriétés pharmaceutiques intéressantes. En particulier, les composés sont utiles dans le traitement et/ou la prévention d'infections telles que celles causées par plasmodium falciparum, plasmodium vivax, plasmodium malariae, plasmodium ovale, trypanosoma cruzi et des parasites du genre leishmania tels que, par exemple, leishmania donovani. L'invention concerne également des compositions pharmaceutiques contenant les composés, ainsi que des procédés pour leur préparation.
MA33365A 2008-04-29 2010-11-19 Derives spiro-indoles pour le traitement de maladies parasitaires MA32316B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08155342 2008-04-29
EP09151117 2009-01-22
PCT/EP2009/053902 WO2009132921A1 (fr) 2008-04-29 2009-04-01 Dérivés spiro-indoles pour le traitement de maladies parasitaires

Publications (1)

Publication Number Publication Date
MA32316B1 true MA32316B1 (fr) 2011-05-02

Family

ID=40613087

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33365A MA32316B1 (fr) 2008-04-29 2010-11-19 Derives spiro-indoles pour le traitement de maladies parasitaires

Country Status (31)

Country Link
US (2) US8053442B2 (fr)
EP (2) EP2285808B1 (fr)
JP (2) JP5438098B2 (fr)
KR (1) KR101390081B1 (fr)
CN (1) CN102015711B (fr)
AR (1) AR071222A1 (fr)
AU (1) AU2009242279B2 (fr)
BR (1) BRPI0911577B8 (fr)
CA (1) CA2719365C (fr)
CL (1) CL2009001007A1 (fr)
CO (1) CO6300940A2 (fr)
CY (1) CY1114874T1 (fr)
DK (1) DK2285808T3 (fr)
EA (1) EA019601B1 (fr)
EC (2) ECSP10010646A (fr)
ES (1) ES2447590T3 (fr)
HK (1) HK1149935A1 (fr)
HR (1) HRP20140151T1 (fr)
IL (1) IL208357A (fr)
JO (1) JO2904B1 (fr)
MA (1) MA32316B1 (fr)
MX (1) MX2010011868A (fr)
MY (2) MY152021A (fr)
NZ (1) NZ588217A (fr)
PE (1) PE20091787A1 (fr)
PL (1) PL2285808T3 (fr)
PT (1) PT2285808E (fr)
SI (1) SI2285808T1 (fr)
TW (1) TWI442921B (fr)
WO (1) WO2009132921A1 (fr)
ZA (1) ZA201006752B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009242279B2 (en) * 2008-04-29 2012-08-30 Novartis Ag Spiro-indole derivatives for the treatment of parasitic diseases
CN102584835B (zh) * 2011-01-17 2014-08-27 苏州大学 一种含吲哚结构的螺杂环化合物及其制备方法
AP2014007906A0 (en) * 2012-03-23 2014-08-31 Novartis Ag Chemical process for preparing spiroindolones and intermediates thereof
EP2828385B1 (fr) 2012-03-23 2018-02-07 Codexis, Inc. Biocatalyseurs et procédés pour la synthèse de dérivés de tryptamine et d'analogues de tryptamine
CN104185634B (zh) * 2012-03-23 2017-05-03 诺华股份有限公司 制备螺旋吲哚酮和其中间体的化学工艺
JP6643987B2 (ja) 2013-11-13 2020-02-12 コデクシス， インコーポレイテッド ケトン化合物およびアミン化合物の還元的アミノ化のための操作されたイミンレダクターゼおよび方法
CN107002050A (zh) 2014-11-25 2017-08-01 科德克希思公司 工程化亚胺还原酶和用于酮和胺化合物的还原胺化的方法
KR20230113416A (ko) 2014-12-18 2023-07-28 에프. 호프만-라 로슈 아게 테트라하이드로-피리도[3,4-b]인돌 에스트로겐 수용체조절제 및 이의 용도
CN107406452B (zh) * 2015-01-23 2019-07-23 葛兰素史密斯克莱知识产权发展有限公司 吡唑并[3,4-d]嘧啶衍生物及其治疗利什曼病的用途
WO2016147205A1 (fr) * 2015-03-13 2016-09-22 Council Of Scientific & Industrial Research Nouveaux 3-spirophosphoryl pyrazole-2-oxindoles substitués en tant qu'agents anti-infectieux et procédé de synthèse correspondant
US11174267B2 (en) 2015-06-12 2021-11-16 The Regents Of The University Of California Spiroindolinones and therapeutic uses thereof
JP2017024992A (ja) * 2015-07-15 2017-02-02 公益財団法人微生物化学研究会 化合物の製造方法
SG11202012171SA (en) 2018-06-21 2021-01-28 Hoffmann La Roche Solid forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use
CN110590795B (zh) * 2019-10-10 2021-01-22 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一类多并杂环螺羟吲哚类化合物的合成方法
WO2021186348A1 (fr) * 2020-03-17 2021-09-23 The University Of Buea Dihydro-spiro[indoline-3:1'-isoquinolin]-2-ones utiles en tant qu'agents antipaludiques

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663935A1 (fr) * 1990-06-27 1992-01-03 Adir Nouveaux 1,2,3,4,5,6-hexahydroazepino [4,5-b] indoles et 1,2,3,4-tetrahydrobethacarbolines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
RU2236413C2 (ru) * 1998-07-14 2004-09-20 Байер Акциенгезельшафт Производные артемизинина, способ их получения, фармацевтическая композиция на их основе и способ лечения
EA004500B1 (ru) 1998-12-19 2004-04-29 Янссен Фармацевтика Н.В. Антигистаминные спиросоединения
US20050143371A1 (en) * 2003-07-23 2005-06-30 Pharmacia Corporation Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
MY145694A (en) 2005-04-11 2012-03-30 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
EP2102207B1 (fr) 2006-12-07 2010-06-02 F.Hoffmann-La Roche Ag Dérivés de spiro-pipéridine
EP2219646A4 (fr) * 2007-12-21 2010-12-22 Univ Rochester Procédé permettant de modifier la durée de vie d'organismes eucaryotes
PE20091315A1 (es) 2008-01-09 2009-09-21 Array Biopharma Inc Ciclopentanos de pirimidilo como inhibidores de la proteina cinasa akt
AU2009242279B2 (en) * 2008-04-29 2012-08-30 Novartis Ag Spiro-indole derivatives for the treatment of parasitic diseases

Also Published As

Publication number Publication date
ZA201006752B (en) 2011-05-25
EP2722333A1 (fr) 2014-04-23
US8053442B2 (en) 2011-11-08
NZ588217A (en) 2012-10-26
KR101390081B1 (ko) 2014-04-29
TWI442921B (zh) 2014-07-01
HK1149935A1 (en) 2011-10-21
MY152021A (en) 2014-08-15
DK2285808T3 (da) 2014-02-03
US20090275560A1 (en) 2009-11-05
KR20100135320A (ko) 2010-12-24
JP2011518852A (ja) 2011-06-30
PL2285808T3 (pl) 2014-04-30
AU2009242279B2 (en) 2012-08-30
ECSP10010646A (es) 2010-12-30
US20110275613A1 (en) 2011-11-10
JP5438098B2 (ja) 2014-03-12
JP2014065729A (ja) 2014-04-17
EP2285808B1 (fr) 2013-11-20
ES2447590T3 (es) 2014-03-12
SI2285808T1 (sl) 2014-03-31
PT2285808E (pt) 2014-02-24
BRPI0911577A2 (pt) 2016-01-05
CO6300940A2 (es) 2011-07-21
US8399453B2 (en) 2013-03-19
WO2009132921A1 (fr) 2009-11-05
EA019601B1 (ru) 2014-04-30
IL208357A (en) 2014-11-30
CA2719365A1 (fr) 2009-11-05
CY1114874T1 (el) 2016-12-14
CA2719365C (fr) 2017-03-07
CL2009001007A1 (es) 2010-06-11
MX2010011868A (es) 2010-11-26
HRP20140151T1 (hr) 2014-03-28
EP2285808A1 (fr) 2011-02-23
IL208357A0 (en) 2010-12-30
CN102015711A (zh) 2011-04-13
ECSP17068127A (es) 2017-10-31
PE20091787A1 (es) 2009-12-14
TW200948357A (en) 2009-12-01
BRPI0911577B1 (pt) 2021-02-23
AU2009242279A1 (en) 2009-11-05
BRPI0911577A8 (pt) 2018-03-06
BRPI0911577B8 (pt) 2021-05-25
CN102015711B (zh) 2013-05-01
JO2904B1 (en) 2015-09-15
AR071222A1 (es) 2010-06-02
EA201001689A1 (ru) 2011-08-30
MY156601A (en) 2016-03-15

Similar Documents

Publication Publication Date Title
MA32316B1 (fr) Derives spiro-indoles pour le traitement de maladies parasitaires
CY1119727T1 (el) Ενωσεις και συνθεσεις για τη θεραπεια παρασιτικων νοσων
CY1119684T1 (el) Αντι-ιικες ενωσεις
EA201200098A1 (ru) Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия
SMT201600055B (it) Composizione farmaceutica per il trattamento o la prevenzione del glaucoma
WO2009152356A3 (fr) Composés et compositions utiles pour le traitement de la malaria
SMT201300109B (it) Imidazopiridazincarbonitrili utili come inibitori di chinasi
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
UA107188C2 (uk) Карбоксамідні похідні хіназолінів або хінолінів та фармацевтична композиція на їх основі
EA201200473A1 (ru) Замещенные (гетероарилметил)тиогидантоины
WO2017142825A3 (fr) Iminopyrimidinones substituées par n3 à titre d'agents antipaludéens
IN2015DN02966A (fr)
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
BR112014004437A8 (pt) composto, composição farmacêutica, preparação farmacêutica, processo para o preparo de um composto de fórmula, intermediário, métodos para a prevenção ou tratamento de malária e para inativação de infecção parasítica em uma célula.
PH12017501072A1 (en) Thiotriazole compound and its use in parasitic protozoal infections
TN2010000458A1 (en) Spiro indole derivatives for the treatment of parasitic diseases
TH106774A (th) อนุพันธ์สไปโร-อินโดลสำหรับการบำบัดโรคจากเชื้อปรสิตสาขาวิทยาการที่เกี่ยวข้องกับการประดิษฐ์
CY1115356T1 (el) Συντηγμeνες ιμιδαζολες και συνθεσεις περιλαμβανοντας αυτες για την αγωγη παρασιτικων παθησεων, οπως ειναι π.χ. η ελονοσια
TH153741A (th) 4-เฟนิล-ไพริดีนที่ได้รับการแทนที่สำหรับการบำบัดของโรคที่เกี่ยวข้องกับตัวรับ nk-1
BR112014013170A2 (pt) vacina para malária causada por falciparum
CY1116711T1 (el) Νεοι ανθελονοσιακοι παραγοντες
TH106831A (th) สารประกอบที่ประกอบด้วยหมู่ไซโคลบิวทอกซีหนึ่งหมู่
TH104144A (th) (ไดไฮโดร)เพอร์โรโล [2,1-เอ]ไอโซควิโนลีน
TH159902A (fr)